344 related articles for article (PubMed ID: 33049978)
1. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with
Nevado RM; Hamczyk MR; Gonzalo P; Andrés-Manzano MJ; Andrés V
Cells; 2020 Oct; 9(10):. PubMed ID: 33049978
[TBL] [Abstract][Full Text] [Related]
2. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
[TBL] [Abstract][Full Text] [Related]
3. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
[TBL] [Abstract][Full Text] [Related]
4. Vascular smooth muscle cell-specific progerin expression in a mouse model of Hutchinson-Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of dietary nitrite.
Del Campo L; Sánchez-López A; Salaices M; von Kleeck RA; Expósito E; González-Gómez C; Cussó L; Guzmán-Martínez G; Ruiz-Cabello J; Desco M; Assoian RK; Briones AM; Andrés V
Aging Cell; 2019 Jun; 18(3):e12936. PubMed ID: 30884114
[TBL] [Abstract][Full Text] [Related]
5. Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome.
Hamczyk MR; Andrés V
Nucleus; 2019 Dec; 10(1):28-34. PubMed ID: 30900948
[TBL] [Abstract][Full Text] [Related]
6. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
Macías Á; Díaz-Larrosa JJ; Blanco Y; Fanjul V; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; da Rocha AM; Ponce-Balbuena D; Allan A; Filgueiras-Rama D; Jalife J; Andrés V
Cardiovasc Res; 2022 Jan; 118(2):503-516. PubMed ID: 33624748
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
[TBL] [Abstract][Full Text] [Related]
9. Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment.
Del Campo L; Sánchez-López A; González-Gómez C; Andrés-Manzano MJ; Dorado B; Andrés V
Cells; 2020 Mar; 9(3):. PubMed ID: 32182706
[TBL] [Abstract][Full Text] [Related]
10. Low levels of the reverse transactivator fail to induce target transgene expression in vascular smooth muscle cells.
Viceconte N; McKenna T; Eriksson M
PLoS One; 2014; 9(8):e104098. PubMed ID: 25090270
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
[TBL] [Abstract][Full Text] [Related]
12. Long term breeding of the Lmna G609G progeric mouse: Characterization of homozygous and heterozygous models.
Zaghini A; Sarli G; Barboni C; Sanapo M; Pellegrino V; Diana A; Linta N; Rambaldi J; D'Apice MR; Murdocca M; Baleani M; Baruffaldi F; Fognani R; Mecca R; Festa A; Papparella S; Paciello O; Prisco F; Capanni C; Loi M; Schena E; Lattanzi G; Squarzoni S
Exp Gerontol; 2020 Feb; 130():110784. PubMed ID: 31794853
[TBL] [Abstract][Full Text] [Related]
13. Arterial stiffness and cardiac dysfunction in Hutchinson-Gilford Progeria Syndrome corrected by inhibition of lysyl oxidase.
von Kleeck R; Roberts E; Castagnino P; Bruun K; Brankovic SA; Hawthorne EA; Xu T; Tobias JW; Assoian RK
Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33687998
[TBL] [Abstract][Full Text] [Related]
14. Vulnerability of progeroid smooth muscle cells to biomechanical forces is mediated by MMP13.
Pitrez PR; Estronca L; Monteiro LM; Colell G; Vazão H; Santinha D; Harhouri K; Thornton D; Navarro C; Egesipe AL; Carvalho T; Dos Santos RL; Lévy N; Smith JC; de Magalhães JP; Ori A; Bernardo A; De Sandre-Giovannoli A; Nissan X; Rosell A; Ferreira L
Nat Commun; 2020 Aug; 11(1):4110. PubMed ID: 32807790
[TBL] [Abstract][Full Text] [Related]
15. Exacerbated atherosclerosis in progeria is prevented by progerin elimination in vascular smooth muscle cells but not endothelial cells.
Benedicto I; Carmona RM; Barettino A; Espinós-Estévez C; Gonzalo P; Nevado RM; de la Fuente-Pérez M; Andrés-Manzano MJ; González-Gómez C; Rolas L; Dorado B; Nourshargh S; Hamczyk MR; Andrés V
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2400752121. PubMed ID: 38648484
[TBL] [Abstract][Full Text] [Related]
16. Hepatic hydrogen sulfide levels are reduced in mouse model of Hutchinson-Gilford progeria syndrome.
Wilkie SE; Marcu DE; Carter RN; Morton NM; Gonzalo S; Selman C
Aging (Albany NY); 2023 Jun; 15(12):5266-5278. PubMed ID: 37354210
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin delays premature aging in Hutchinson-Gilford progeria syndrome.
Ferreira-Marques M; Carvalho A; Franco AC; Leal A; Botelho M; Carmo-Silva S; Águas R; Cortes L; Lucas V; Real AC; López-Otín C; Nissan X; de Almeida LP; Cavadas C; Aveleira CA
Aging Cell; 2023 Dec; 22(12):e13983. PubMed ID: 37858983
[TBL] [Abstract][Full Text] [Related]
18. Bone dysplasia in Hutchinson-Gilford progeria syndrome is associated with dysregulated differentiation and function of bone cell populations.
Cabral WA; Stephan C; Terajima M; Thaivalappil AA; Blanchard O; Tavarez UL; Narisu N; Yan T; Wincovitch SM; Taga Y; Yamauchi M; Kozloff KM; Erdos MR; Collins FS
Aging Cell; 2023 Sep; 22(9):e13903. PubMed ID: 37365004
[TBL] [Abstract][Full Text] [Related]
19. Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome.
Kang SM; Seo S; Song EJ; Kweon O; Jo AH; Park S; Woo TG; Kim BH; Oh GT; Park BJ
Cells; 2023 Apr; 12(9):. PubMed ID: 37174632
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.
Benedicto I; Dorado B; Andrés V
Cells; 2021 May; 10(5):. PubMed ID: 34064612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
